期刊文献+

Baicalein protects against the development of angiotensin II-induced abdominal aortic aneurysms by blocking JNK and p38 MAPK signaling 被引量:7

Baicalein protects against the development of angiotensin II-induced abdominal aortic aneurysms by blocking JNK and p38 MAPK signaling
原文传递
导出
摘要 An abdominal aortic aneurysm(AAA) is a permanent, localized dilatation of the abdominal aorta. In western countries, the morbidity of AAA is approximately 8%. Currently, pharmacotherapies for AAA are limited. Here, we demonstrate that baicalein(BAI), the main component of the Chinese traditional drug "Huang Qin", attenuates the incidence and severity of AAA in Apoe儃/儃 mice infused with angiotensin II(AngII). Mechanically, BAI treatment decreases AngII-induced reactive oxygen species(ROS) production in the aortic wall. Moreover, BAI inhibits inflammatory cell accumulation in the aortas of mice infused with AngII. It also inhibits AngII-induced activation of matrix metalloproteinase 2(MMP-2) and MMP-9 to maintain elastin content in vivo. In addition, it blocks AngII cascade by downregulating angiotensin type 1 receptor(AT1R) and inhibiting mitogen-activated protein kinases(MAPKs). Taken together, our findings show that BAI is an effective agent for AAA prevention. An abdominal aortic aneurysm(AAA) is a permanent, localized dilatation of the abdominal aorta. In western countries, the morbidity of AAA is approximately 8%. Currently, pharmacotherapies for AAA are limited. Here, we demonstrate that baicalein(BAI), the main component of the Chinese traditional drug "Huang Qin", attenuates the incidence and severity of AAA in Apoe儃/儃 mice infused with angiotensin II(AngII). Mechanically, BAI treatment decreases AngII-induced reactive oxygen species(ROS) production in the aortic wall. Moreover, BAI inhibits inflammatory cell accumulation in the aortas of mice infused with AngII. It also inhibits AngII-induced activation of matrix metalloproteinase 2(MMP-2) and MMP-9 to maintain elastin content in vivo. In addition, it blocks AngII cascade by downregulating angiotensin type 1 receptor(AT1R) and inhibiting mitogen-activated protein kinases(MAPKs). Taken together, our findings show that BAI is an effective agent for AAA prevention.
出处 《Science China(Life Sciences)》 SCIE CAS CSCD 2016年第9期940-949,共10页 中国科学(生命科学英文版)
基金 supported by the National Natural Science Foundation of China(31571193,81422002,91339201)
关键词 BAICALEIN abdominal aortic aneurysm oxidative stress vascular inflammation extracellular matrix degradation AT1R MAPKS 血管紧张素II MAPK 动脉瘤 黄芩素 信号转导 p38 JNK 丝裂原活化蛋白激酶
  • 相关文献

参考文献34

  • 1Annambhotla S., Bourgeois S., Wang X., Lin P.H., Yao Q., Chen C.. Recent Advances in Molecular Mechanisms of Abdominal Aortic Aneurysm Formation. World J Surg, 2008, 32: 976-986.
  • 2Bergoeing M.P., Thompson R.W., Curci J.A.. Pharmacological targets in the treatment of abdominal aortic aneurysms. Expert Opin on Therapeutic Targets, 2006, 10: 547-559.
  • 3Brewster, D.C., Cronenwett, J.L., Hallett, J.W., Jr., Johnston, K.W., Krupski, W.C., and Matsumura, J.S. (2003). Guidelines for the treatment of abdominal aortic aneurysms. Report of a subcommittee of the Joint Council of the American Association for Vascular Surgery and Society for Vascular Surgery. J Vasc Surg 37, 1106–1117.
  • 4Daugherty A., Cassis L.A.. Mouse Models of Abdominal Aortic Aneurysms. Arteriosclerosis Thrombosis Vascular Biol, 2004, 24: 429-434.
  • 5Finkel T., Holbrook N.J.. Oxidants, oxidative stress and the biology of ageing. Nature, 2000, 408: 239-247.
  • 6Galis, Z.S., and Khatri, J.J. (2002). Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res 90, 251–262.
  • 7Gao Z., Huang K., Yang X., Xu H.. Free radical scavenging and antioxidant activities of flavonoids extracted from the radix of Scutellaria baicalensis Georgi. Biochimica Biophysica Acta (BBA) - General Subjects, 1999, 1472: 643-650.
  • 8Golledge J., Powell J.T.. Medical Management of Abdominal Aortic Aneurysm. Eur J Vascular Endovascular Surgery, 2007, 34: 267-273.
  • 9Griendling, K.K., Lassegue, B., and Alexander, R.W. (1996). Angiotensin receptors and their therapeutic implications. Annu Rev Pharmacol Toxicol 36, 281–306.
  • 10Hawkes, S.P., Li, H., and Taniguchi, G.T. (2010). Zymography and reverse zymography for detecting MMPs and TIMPs. Methods Mol Biol 622, 257–269.

同被引文献51

引证文献7

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部